# A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients

> **NCT04220762** · PHASE2 · UNKNOWN · sponsor: **Medi Help Line** · enrollment: 188 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** WIN-1001X
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04220762
- **Lead sponsor:** Medi Help Line
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-21
- **Primary completion:** 2021-06
- **Final completion:** 2021-09
- **Target enrollment:** 188 (ESTIMATED)
- **Last updated:** 2021-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04220762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04220762, "A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04220762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*